Humanized Mice
General information
CD34+ humanized mice are model animals constructed by transportation of human umbilical cord blood and fetal liver hematopoietic stem cells (HSCs) into irradiated myeloablative NMG mice. HSCs can colonize in the bone marrow of mice after transplantation and continuously produce various types of hematopoietic or immune cells, such as T cells, B cells, NK cells, and myeloid cells. Since the immune cells are developed in mice and are tolerant to the host, no GvHD will be observed, human-derived immune cells will exist stably, and the types of reconstructed immune cells will be richer than those of PBMC humanized mice. However, the T cell function of this model type is relatively weak due to lack of human thymus required for human T cell development. In addition, the myeloid cells of this model are underdeveloped, and the content of NK cells is relatively low, because the species differences between humans and mice are demonstrated by certain cytokines that regulate the development of these two types of cells.
IL-15 is essential for the development of NK cells, natural killer T cells, and memory CD8+ T cells. The supplementation of human IL-15 by Shanghai Model Organisms Center on the basis of conventional CD34+ humanized mice is able to significantly increase the proportion of NK cells to be suitable for the efficacy evaluation of drug targets on NK cells.
Preparation process
Figure 1. Preparation process of NMG mice transplanted with human hematopoietic stem cells (HSCs).
Phenotypic analysis
Figure 2. Reconstructed hematopoietic system of NMG mice transplanted with human hematopoietic stem cells (HSCs), indicating continuously increased level of human-derived CD45+ immune cells in peripheral blood.
Figure 3. Proportions of various types of hematopoietic/immune cells at 20 weeks after the mice are transplanted with human hematopoietic stem cells (HSCs), including human-derived T (CD3+CD4+ and CD3+CD8+ cells), B (CD19+ cells), NK lymphocytes (CD56+CD16+ cells), and monocytes (CD14+CD11b+ cells).
Figure 4. Reconstructed hematopoietic system of NMG mice transplanted with human hematopoietic stem cells (HSCs), with supplementation of human-derived IL-15, which can significantly increase the proportion of NK cells and is suitable for the efficacy evaluation of drug targets on NK cells.
Efficacy evaluation
Figure 5. Example 1 of anti-tumor efficacy validation in Hu-HSC tumor-bearing mouse model
Figure 6. Example 2 of anti-tumor efficacy validation in Hu-HSC tumor-bearing mouse model
Application field
Immuno-oncology study
Hematological disease study
Infectious disease study
Gene therapy
Study on drug targets without cross reactions
Immunogenicity assay
If you need to place an order, please feel free to contact us: 400-728-0660 or tech@modelorg.com.
Popular articles
Cre-ERT2在无Tamoxifen诱导的情况下,在细胞质内处于无活性状态;当Tamoxifen诱导后,Tamoxifen的代谢产物4-OHT(雌激素类似物)与ERT结合,可使Cre-ERT2进核发挥Cre重组酶活性。
Learn more你一定听说过Cre-lox重组系统,无论你是否直接进行过基因操作。由于Cre-lox系统具有操作简单、重组率高的优点,如今已经成为体内外遗传操作的强有力工具。利用Cre-lox系统,可以在特定细胞、组织或整个生物体,甚至在特定时间点敲除或表达某个基因,实现对特定基因的时空特异性操作,这对基因功能的研究和人类疾病动物模型的建立都具有深刻影响。
Learn more